Detail Information of Post-Translational Modifications
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0406 Transporter Info | ||||
Gene Name | SLC56A4 | ||||
Transporter Name | Sideroflexin-4 | ||||
Gene ID | |||||
UniProt ID | |||||
Post-Translational Modification of This DT | |||||
Overview of SLC56A4 Modification Sites with Functional and Structural Information | |||||
Sequence |
MSLEQEEETQ PGRLLGRRDA VPAFIEPNVR FWITERQSFI RRFLQWTELL DPTNVFISVE
SIENSRQLLC TNEDVSSPAS ADQRIQEAWK RSLATVHPDS SNLIPKLFRP AAFLPFMAPT VFLSMTPLKG IKSVILPQVF LCAYMAAFNS INGNRSYTCK PLERSLLMAG AVASSTFLGV IPQFVQMKYG LTGPWIKRLL PVIFLVQASG MNVYMSRSLE SIKGIAVMDK EGNVLGHSRI AGTKAVRETL ASRIVLFGTS ALIPEVFTYF FKRTQYFRKN PGSLWILKLS CTVLAMGLMV PFSFSIFPQI GQIQYCSLEE KIQSPTEETE IFYHRGV |
||||
PTM type |
X-Acetylation
X-Oxidation
X-Phosphorylation
X-S-nitrosylation
X-Ubiquitination
X: Amino Acid
|
Acetylation |
|||||
---|---|---|---|---|---|
Lysine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC56A4 | [1] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
197 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Acetylation at SLC56A4 Lysine 197 has the potential to affect its expression or activity. | ||||
Serine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC56A4 | [2] , [3] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
2 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Acetylation at SLC56A4 Serine 2 has the potential to affect its expression or activity. | ||||
Oxidation |
|||||
Cystine |
2 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SFXN4 | [4] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Cystine |
Modified Location |
70 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Oxidation at SFXN4 Cystine 70 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SFXN4 | [4] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Cystine |
Modified Location |
159 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Oxidation at SFXN4 Cystine 159 has the potential to affect its expression or activity. | ||||
Phosphorylation |
|||||
Serine |
3 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC56A4 | [5] , [6] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
2 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC56A4 Serine 2 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC56A4 | [7] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
101 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC56A4 Serine 101 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 3 |
Have the potential to influence SLC56A4 | [8] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
324 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC56A4 Serine 324 has the potential to affect its expression or activity. | ||||
Threonine |
2 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC56A4 | [9] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
9 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC56A4 Threonine 9 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC56A4 | [8] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
326 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC56A4 Threonine 326 has the potential to affect its expression or activity. | ||||
S-nitrosylation |
|||||
Cystine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SFXN4 | [10] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Cystine |
Modified Location |
159 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
S-nitrosylation (-SNO) at SFXN4 Cystine 159 has the potential to affect its expression or activity. | ||||
Ubiquitination |
|||||
Alanine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC56A4 | [11] , [12] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Alanine |
Modified Location |
81 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC56A4 Alanine 81 has the potential to affect its expression or activity. | ||||
Histidine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC56A4 | [12] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Histidine |
Modified Location |
97 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC56A4 Histidine 97 has the potential to affect its expression or activity. | ||||
Leucine |
2 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC56A4 | [12] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Leucine |
Modified Location |
107 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC56A4 Leucine 107 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC56A4 | [11] , [12] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Leucine |
Modified Location |
114 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC56A4 Leucine 114 has the potential to affect its expression or activity. | ||||
Lysine |
5 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC56A4 | [11] , [13] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
106 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC56A4 Lysine 106 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLC56A4 | [11] , [12] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
188 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC56A4 Lysine 188 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 3 |
Have the potential to influence SLC56A4 | [11] , [13] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
197 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC56A4 Lysine 197 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 4 |
Have the potential to influence SLC56A4 | [11] , [13] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
223 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC56A4 Lysine 223 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 5 |
Have the potential to influence SLC56A4 | [11] , [13] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
230 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC56A4 Lysine 230 has the potential to affect its expression or activity. | ||||
Serine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC56A4 | [11] , [12] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
221 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC56A4 Serine 221 has the potential to affect its expression or activity. | ||||
Tyrosine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC56A4 | [12] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Tyrosine |
Modified Location |
214 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC56A4 Tyrosine 214 has the potential to affect its expression or activity. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.